Michał Sołowow invested in OncoArendi Therapeutics Sp. z o.o.
On January 15, 2015 Michał Sołowow invested in OncoArendi Therapeutics Sp. z o.o. via the IPOPEMA 112 FIZAN fund. OncoArendi is a dynamically growing biotechnological company, which develops innovative anti-inflammatory and antitumor drugs with unique mechanisms of
Read more